Core Insights - Zepp Health Corporation reported strong financial results for the fourth quarter and full year of 2025, with significant revenue growth and improved gross margins, indicating a successful transition to a premium-focused brand [1][2]. Financial Highlights Fourth Quarter 2025 - Revenue reached US$85.2 million, representing a 43.0% year-over-year increase and meeting the upper end of guidance [1][2]. - Gross margin achieved a record level of 40.4%, an increase of 3.6 percentage points from Q4 2024 [1][2]. - The company narrowed its GAAP net loss to US$11.0 million, a significant improvement from a loss of US$36.9 million in Q4 2024 [1][3]. - Adjusted operating loss was reduced to US$2.7 million from US$7.4 million in Q4 2024, reflecting effective cost control and revenue growth [2][3]. Full Year 2025 - Total revenue for the year was US$258.9 million, a 41.8% increase from US$182.6 million in 2024 [1][4]. - Gross margin for the full year was 38.3%, slightly down from 38.5% in 2024, but the company remains on track with its margin-expansion strategy [1][4]. - The net loss for the year was US$40.1 million, significantly improved from a loss of US$75.7 million in 2024 [1][4]. Product Development and Market Strategy - The company expanded its Amazfit Athletes team, adding notable athletes to enhance brand visibility and engagement [1]. - New product launches included the Amazfit Active Max, Amazfit T-Rex Ultra 2, and Amazfit Active 3 Premium, aimed at various market segments [1][2]. - The company emphasized its transition from a volume-driven brand to a premium-focused global brand, enhancing pricing power and community engagement [1][3]. Cash and Inventory Management - As of December 31, 2025, cash and cash equivalents increased to US$112.9 million from US$102.6 million as of September 30, 2025, driven by strong operating performance [1][2]. - Inventory decreased to US$72.8 million from US$87.7 million, reflecting improved inventory management practices [1][2]. Outlook - For Q1 2026, management expects net revenues to be between US$50.0 million and US$55.0 million, indicating a year-over-year increase of approximately 30% to 43% [1][4].